Kyle Schaub, OD
Optometrist · Sarasota, FLNPI 1679682777
Payments from drug & device makers
Across 86 payments — averaging $40.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$525
- Alcon$490
- Tarsus Pharmaceuticals, Inc.$489
- Johnson & Johnson Vision Care, Inc.$250
- Rxsight Inc$246
- Glaukos Corporation$243
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,442100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $525 |
| Alcon | 12 | $490 |
| Tarsus Pharmaceuticals, Inc. | 12 | $489 |
| Johnson & Johnson Vision Care, Inc. | 10 | $250 |
| Rxsight Inc | 2 | $246 |
| Glaukos Corporation | 2 | $243 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $181 |
| Aerie Pharmaceuticals, Inc. | 3 | $161 |
| Bausch & Lomb Americas Inc. | 8 | $150 |
| Ivantis, Inc | 1 | $136 |
| Dompe US, Inc. | 1 | $123 |
| Apellis Pharmaceuticals, Inc. | 1 | $106 |
| Lombart Brothers, Inc. | 1 | $93 |
| Novartis | 3 | $68 |
| Sun Pharmaceutical Industries Inc. | 2 | $55 |
| Harrow Eye, LLC | 2 | $42 |
| Ocular Therapeutix, Inc. | 2 | $38 |
| Coopervision Inc. | 2 | $27 |
| Omeros Corporation | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XDEMVY$244
- COMBIGAN$166
- LUMIGAN$166
- DAILIES$138
- Hydrus Microstent$136
- Tecnis IOL$135
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$130
- TRYPTYR$125
- Oxervate$123
- Rhopressa$122
- Rocklatan$122
- RXSIGHT CONTACT LENS$115
- RXSIGHT INJECTOR CARTRIDGE$115
- RXSIGHT INJECTOR HANDPIECE$115
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$115
- LIGHT ADJUSTABLE LENS (LAL)$115
- Syfovre$106
How this compares
$3,442 in reported general payments places this provider in the 80th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XdemvyLotilaner | 75 | $140,671 |
| RestasisCyclosporine | 52 | $63,682 |
| LumiganBimatoprost | 80 | $51,281 |
| XiidraLifitegrast | 21 | $36,037 |
| RocklatanNetarsudil Mesylat/Latanoprost | 39 | $18,838 |
| Cyclosporine | 22 | $15,341 |
| RhopressaNetarsudil Mesylate | 27 | $14,078 |
| Latanoprost | 642 | $8,551 |
| CequaCyclosporine | 11 | $7,340 |
| Fluorometholone | 66 | $6,391 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 22 | $5,352 |
| Travoprost | 37 | $4,942 |
| Prednisolone Acetate | 84 | $3,417 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 173 | $2,890 |
| Brimonidine Tartrate | 99 | $2,728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Tarsus Pharmaceuticals, Inc.Xdemvy | $489 | $140,67175 claims |
| AbbVieRestasis, Lumigan | $525 | $114,962132 claims |
| Bausch & Lomb Americas Inc.Xiidra | $150 | $36,03721 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $161 | $32,91766 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $55 | $7,34011 claims |
| AlconSimbrinza | $490 | $5,35222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,166 optometrist providers in Florida.
Other optometrist in Sarasota
- Wayne GoldenSarasota$359K
- Scott HanSarasota$151K
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
- Oksana SovaJacksonville$841K
- James HoffmanOrange Park$795K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.